Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
glenmark
10 Tablet
Everolimus
Keep in cold place
Delivering To:
Overview
Evermil 5mg Tablet belongs to the category of anticancer medicines. These medicines are primarily used to treat patients diagnosed with breast, pancreatic, brain, lung, and kidney cancer. The growth of cancer cells is uncontrollable and abnormal in the human body. It is difficult to diagnose cancer in the early stages. When diagnosed in advanced stages, only the symptoms of the disease can be reduced. Evermil Tablet is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.
Kidney Cancer, Noncancerous tumors, Breast Cancer, Brain tumor, kidney tumor,Partial-onset seizures
Breast cancer
Lung cancer
Pancreatic cancer
Kidney cancer
Prevention of organ rejection in transplant patients
The human body shows undesired symptoms after taking Evermil 5mg Tablet. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Evermil Tablet are mentioned below:
Fever
Hair loss
Infection
BleedingDizzinessCoughing
Wheezing
Tiredness
Dry mouth
Muscle pain
Excessive thirst
Increased appetite
Serious side effects:
Difficulty breathing and swallowing
Swelling on face, lips, tongue, throat
Severe itching, red rash, raised bumps
As directed by your physician, take this medication for the prescribed duration. Eat it all at once. Avoid chewing, crushing, or breaking it. It is preferable to take Evermil 5 Tablet at a set time, but it can be taken with or without food.
Evermil 5mg Tablet works by stopping the activity of a protein known as a mammalian target of rapamycin (mTOR). This protein is responsible for cell growth and division. Evermil Tablet slows down the growth of cancerous cells by blocking the production of the mTOR protein. It also reduces the size of the tumor and prevents cancer from spreading to other parts of the body.
Alcohol
consult your doctor
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Evermil 5mg Tablet. It is advised to consult your doctor for further information.
Pregnancy
consult your doctor
Evermil 5mg Tablet may be considered unsafe during pregnancy. Please consult your doctor in such condition.
Breast Feeding
consult your doctor
Evermil 5mg Tablet is probably not safe if you're breastfeeding. Kindly consult your doctor.
Driving
unsafe
It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Evermil 5mg Tablet.
Kidney
safe if prescribed
Share your medical history with your healthcare expert in case of kidney disease before taking Evermil 5mg Tablet.
Liver
safe if prescribed
Inform your doctor before starting Evermil 5mg Tablet if you have liver disease to avoid any serious side effects.
It is advised not to miss any scheduled dosage of Evermil 5mg Tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
It is advised to use effective birth control ways and avoid pregnancy during the treatment with Evermil 5mg Tablet.
A person should avoid smoking while undergoing treatment with Evermil 5mg Tablet. Smoking may reduce the effectiveness of medicine.
Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), and Heart function at proper intervals after taking Evermil 5mg Tablet.
Swelling of hands, lips, and weight gain are some of the side effects observed after taking Evermil 5mg Tablet. To reduce them, the doctor may suggest some medication.
Skin becomes extremely sensitive after taking Evermil 5mg Tablet. It is advised to cover your skin exposed to direct sun rays and use high SPF sunscreen before going out.
It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Evermil 5mg Tablet, as it may reduce the effectiveness of the medicine.
Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking Evermil 5mg Tablet. Consult your doctor if it doesn't stop or if blood appears in your stools.
In case you notice symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Evermil 5mg Tablet, consult your doctor immediately before these symptoms become severe.
The rate of getting detected with bacterial and viral infections increases while taking this medicine. In case a person has Hepatitis B, Evermil Tablet drug increases the chances of getting the infection again. It is important to share with your healthcare expert if you experience fever, chills, cough, or swelling during the treatment.
A person taking this medicine may experience fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing.
No, A person should avoid any surgical procedure if taking Evermil Tablet. This medicine may result in poor wound healing ability. It is advised to consult your doctor for more information.
It is important to check the body vitals regularly while taking Evermil 5mg Tablet. The doctor will advise for blood tests, KFT & LFT, blood glucose levels, and cholesterol levels.
Any person taking Evermil 5mg Tablet should avoid grapefruit or grapefruit juice. As this medicine may interrupt the effectiveness of the medicine.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Bengueddache, S., Cook, M., Lehmann, S., Arroyo, D., Togni, M., Puricel, S., & Cook, S. (2024). Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. Everolimus-eluting bioresorbable vascular scaffolds—Insights from the EVERBIO-2 trial. Frontiers in Cardiovascular Medicine, 11(4), 1426348.
Bingqi Zhuang, Chongning Zhong, Yuting Ma, Ao Wang, Hailian Quan, Lan Hong (2024). Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells, International Journal of Molecular Sciences, 10.3390/ijms26010231, 26, 1, (231).
De Simone, P., Precisi, A., Lai, Q., Ducci, J., Campani, D., Marchetti, P., & Gitto, S. (2024). Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers, 16(7), 1243
Fort-Casamartina, E., Pernas, S., Otero, S., Mate, P., Gonzalo, N., Narváez, S., Rigo-Bonnin, R., Padró-Miquel, A., Teulé, À., Garcia del Muro, X., Peiró, I., Arribas, L., Esteve, A., Gonzalez, A., Rey, M., Clopés, A., Fontanals, S., & Muñoz, C. (2025). Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). Journal of Clinical Medicine, 14(1), 145.
Gulati S, Tangen C, Ryan CW, et al. (2024) Adjuvant Everolimus in Non–Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open.7(8):e2425288.
Powles, T., Choueiri, T. K., Albiges, L., Peltola, K., de Velasco, G., Burotto, M., Suarez, C., Ghatalia, P., Iacovelli, R., Lam, E. T., Verzoni, E., Gümüş, M., Stadler, W. M., Kollmannsberger, C., Melichar, B., Venugopal, B., Gross‑Goupil, M., Poprach, A., De Santis, M., Rizzo, M., Shinde, R., Saretsky, T. L., He, L., Perini, R. F., & Vickery, D. (2025). Health‑related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK‑005): Patient‑reported outcomes from a randomized, open‑label, phase 3 trial. Lancet Oncology, 26(4), 491–502.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux GP, Hardwigsen J, Benkhatar Y, Derquenne F, Conti F.(2025) Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study. Liver Int. Nov;42(11):2513-2523.
Taboada, R. G., Brito, A. B., Silva, A. L., Weschenfelder, R. F., & Riechelmann, R. P. (2024). The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors. Cancers, 16(22), 3773.
glenmark
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.